Abbott's Next Generation SCS System Provides Broader Pain Coverage
The FDA has approved the Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of chronic pain.
Stay updated with breaking news from Proclaim Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved the Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of chronic pain.
Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff
The US Food and Drug Administration has approved the Proclaim Plus spinal cord stimulation system with FlexBurst360 therapy, which provides personalized coverage at up to six pain points.
NORTH CHICAGO (dpa-AFX) - Abbott (ABT) announced the FDA has approved its new Proclaim Plus spinal cord stimulation system which gives physicians the ability to treat multi-site pain. The system
Abbott's new Proclaimâ„¢ Plus spinal cord stimulation (SCS) system offers the next generation of stimulation therapy, giving physicians the ability to treat...